Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-05-30 Sale | 2024-05-31 9:36 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. | 60,000 | $12.05 | $723,055 | 722,248 (Direct) | View |
2022-02-22 Sale | 2022-02-23 5:15 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $7.85 | $31,400 | 181,077 (Direct) | View |
2022-02-04 Sale | 2022-02-07 5:16 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas | 4,000 | $7.97 | $31,880 | 185,077 (Direct) | View |
2022-01-24 Sale | 2022-01-25 5:01 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $9.84 | $39,360 | 189,077 (Direct) | View |
2022-01-04 Sale | 2022-01-05 5:15 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $17.12 | $68,480 | 193,077 (Direct) | View |
2021-12-22 Sale | 2021-12-23 4:55 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $16.36 | $65,440 | 197,077 (Direct) | View |
2021-12-06 Sale | 2021-12-07 5:16 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $16.35 | $65,400 | 201,077 (Direct) | View |
2021-11-22 Sale | 2021-11-23 5:06 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $18.09 | $72,360 | 205,077 (Direct) | View |
2021-11-04 Sale | 2021-11-05 5:16 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $27.54 | $110,160 | 209,077 (Direct) | View |
2021-10-22 Sale | 2021-10-26 6:04 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $25.94 | $103,760 | 213,077 (Direct) | View |
2021-10-04 Sale | 2021-10-05 5:16 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $28.78 | $115,120 | 217,077 (Direct) | View |
2021-09-22 Sale | 2021-09-23 5:15 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $30.82 | $123,280 | 221,077 (Direct) | View |
2021-09-07 Sale | 2021-09-08 5:31 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $32.03 | $128,120 | 225,077 (Direct) | View |
2021-08-23 Sale | 2021-08-24 5:02 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $28.6 | $114,400 | 229,077 (Direct) | View |
2021-08-04 Sale | 2021-08-05 5:20 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $33.72 | $134,880 | 233,077 (Direct) | View |
2021-07-22 Sale | 2021-07-26 06:19 am | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $34.5 | $138,000 | 237,077 (Direct) | View |
2021-07-06 Sale | 2021-07-07 6:00 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $34.15 | $136,600 | 241,077 (Direct) | View |
2021-06-22 Sale | 2021-06-23 4:30 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $36.17 | $144,680 | 245,077 (Direct) | View |
2021-06-04 Sale | 2021-06-07 4:30 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $33.48 | $133,920 | 249,077 (Direct) | View |
2021-05-24 Sale | 2021-05-26 4:33 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 4,000 | $35.61 | $142,440 | 253,077 (Direct) | View |
2020-05-13 Sale | 2020-05-15 4:15 pm | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secy & Treas. | 100,000 | $36.65 | $3,665,321 | 257,077 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-30 Exercise | 2024-05-31 9:36 pm | N/A N/A | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. | 60,000 | $2 | 722,248 (Direct) | View |
2024-05-30 Exercise | 2024-05-31 9:36 pm | N/A 2025-06-10 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. | 60,000 | $0 | 722,248 (Direct) | View |
2024-01-18 Option Award | 2024-01-22 5:48 pm | N/A 2034-01-18 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, SECRY & TREAS. | 127,000 | $0 | 319,777 (Direct) | View |
2023-01-17 Option Award | 2023-01-19 4:34 pm | N/A 2033-01-17 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secry & Treas. | 81,800 | $0 | 262,877 (Direct) | View |
2022-04-26 Option Award | 2022-04-28 6:16 pm | N/A 2032-04-26 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 75,000 | $0 | 75,000 (Direct) | View |
2021-12-14 Option Award | 2021-12-16 6:01 pm | N/A 2031-12-14 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secretary & Treas. | 85,000 | $0 | 85,000 (Direct) | View |
2020-12-15 Option Award | 2020-12-16 6:05 pm | N/A 2030-12-15 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secy & Treas. | 72,350 | $0 | 72,350 (Direct) | View |
2020-01-07 Option Award | 2020-01-09 6:00 pm | N/A 2030-01-07 | Y-mAbs Therapeutics Inc. | YMAB | Kruse Bo EVP, CFO, Secy & Treas. | 130,000 | $0 | 130,000 (Direct) | View |